Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Auditor change
|
|
Vaxart, Inc. (VXRT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Watson W. Mark (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Bought 20,000 shares
@ $0.757, valued at
$15.1k
|
|
| 10/07/2022 |
4
| Yedid Robert A. (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Sold 1,500 shares
@ $6.0101, valued at
$9k
|
|
| 08/26/2022 |
4
| Yedid Robert A. (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Gifted 18,240 shares
@ $0
Gifted 4,000 shares
@ $0 |
|
| 08/25/2022 |
4
| HERON ELAINE J (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 14,750 shares
@ $0
Granted 88,448 options to buy
@ $3.36, valued at
$297.2k
|
|
| 08/22/2022 |
4
| Yedid Robert A. (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Exercised 18,240 options to buy
@ $0.31, valued at
$5.7k
Exercised 8,000 options to buy
@ $2.39, valued at
$19.1k
|
|
| 08/08/2022 |
4
| Watson W. Mark (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 14,750 shares
@ $0
Granted 88,448 options to buy
@ $3.91, valued at
$345.8k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Wheadon David E. (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 7,375 shares
@ $0
Granted 44,224 options to buy
@ $3.91, valued at
$172.9k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 7,375 shares
@ $0
Granted 44,224 options to buy
@ $3.91, valued at
$172.9k
|
|
| 08/08/2022 |
4
| Cherrington Julie M (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 6,217 shares
@ $0
Granted 37,280 options to buy
@ $3.91, valued at
$145.8k
|
|
| 06/23/2022 |
4
| Ahmad Fuad (Interim CFO) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Bought 5,000 shares
@ $3.22, valued at
$16.1k
|
|
| 04/25/2022 |
4
| Tucker Sean (SVP, Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Exercised 40,000 options to buy
@ $0.77, valued at
$30.8k
|
|
| 03/30/2022 |
4
| Cummings James F. (Chief Medical Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 43,750 shares
@ $0
Granted 262,500 options to buy
@ $5.09, valued at
$1.3M
|
|
| 03/30/2022 |
4
| Floroiu Cezar Andrei (President, Chief Exec Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 85,000 shares
@ $0
Granted 550,000 options to buy
@ $5.09, valued at
$2.8M
|
|
| 03/30/2022 |
4
| Tucker Sean (SVP, Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 43,750 shares
@ $0
Granted 262,500 options to buy
@ $5.09, valued at
$1.3M
|
|
| 02/22/2022 |
4
| Berg Edward B (SVP, General Counsel) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 285,000 options to buy
@ $5.07, valued at
$1.4M
|
|
| 12/23/2021 |
4
| Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Gifted 1,470 shares
@ $0 |
|
| 12/01/2021 |
4
| Echerd Margaret (SVP, Principal Accntng Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Sold 3,602 shares
@ $8, valued at
$28.8k
Exercised 666 options to buy
@ $5.17, valued at
$3.4k
Exercised 2,936 options to buy
@ $0.77, valued at
$2.3k
|
|
| 10/13/2021 |
4
| Yedid Robert A. (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Gifted 1,500 shares
@ $0
Gifted 1,500 shares
@ $0 |
|
| 09/13/2021 |
4
| Echerd Margaret (SVP, Principal Accntng Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Sold 1,801 shares
@ $9.1, valued at
$16.4k
Exercised 334 options to buy
@ $5.17, valued at
$1.7k
Exercised 1,467 options to buy
@ $0.77, valued at
$1.1k
|
|
| 08/23/2021 |
4
| Cherrington Julie M (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 65,700 options to buy
@ $8.34, valued at
$547.9k
|
|
| 08/11/2021 |
4
| Tucker Sean (SVP, Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Sold 4,172 shares
@ $10.2, valued at
$42.6k
Sold 5,828 shares
@ $10.2, valued at
$59.4k
|
|
|
|
|